Too slowly but Surely, the Truth is Coming out
Commentaries by Robert Gorter, MD, PhD
April 16th, 2021
Tyler Durden’s own photo
Do not you hate it when what you get turns out to be far different from what you were promised? In this article, I am only going to share facts that have been documented by corporate media sources. These facts are going to upset a lot of people because they prove that much of what we had been promised didn’t turn out to be true. So many people that I know were convinced that if they just got their two shots they would be 100 percent protected for the rest of their lives and they would never have to be concerned about getting COVID ever again. In addition, most Americans still seem to believe that if a high enough percentage of the population gets their shots COVID will be defeated and the pandemic will be brought to an end. Unfortunately, all of those assumptions have turned out to be dead wrong.
Pfizer CEO Albert Bourla said people will “likely” need a booster dose of a Covid-19 vaccine within 12 months of getting fully vaccinated: and likely, each year thereafter. His comments were made public Thursday but were taped on April 1, 2021.
Bourla said it is very possible people will need to get vaccinated against the coronavirus annually, additionally to the regular yearly flu shots.
“A likely scenario is that there will be likely a need for a third dose, somewhere between six and 12 months and then from there, there will be annual revaccination, but all of that needs to be confirmed. And again, the variants will play a key role,” he told CNBC’s Bertha Coombs during an event with CVS Health.
“It is extremely important to suppress the pool of people that can be susceptible to the virus,” Bourla said.
The comment comes after Johnson & Johnson CEO Alex Gorsky told CNBC in February that people may need to get vaccinated against Covid-19 annually, just like seasonal flu shots.
If you do not want to believe me, perhaps you will believe the CEO of Pfizer himself. This week (April 2021), he admitted that “fully vaccinated” people will need a third shot of the vaccine within 12 months… and likely every 12 months again.
Bourla said it is possible people will need to get vaccinated against the coronavirus annually.
From the very beginning of this crisis, I have been warning that any immunity would be very temporary because of the different techniques by mRNA. Natural COVID immunity is life-long but immunity conferred by the mRNA vaccines is very temporary.
The CEO of Pfizer is comparing the COVID vaccines to flu shots. Every year millions of Americans rush out to get their flu shots and the CEO of Pfizer is admitting that it looks like the COVID vaccines will be on a similar schedule…
“There are vaccines like against polio that one dose is enough, there are vaccines like a pneumococcal vaccine that one dose is enough for adults and there are vaccines like flu that you need every year,” Bourla said. “The Covid virus looks more like the influenza virus than the poliovirus.”
If people are going to need a new shot every year that means that COVID will be with us for decades to come.
This is essentially an admission that the COVID pandemic will not be ending any time soon.
Needless to say, Pfizer stands to make giant mountains of money if COVID vaccines become a yearly thing, and we need to keep that in mind.
A lot of people that I know are going to be extremely upset when they finally realize that the two shots that they got only provide temporary immunity.
And of course, lots of people are still getting sick after being fully vaccinated. According to the CDC, so far there have been almost 6,000 documented cases of people being infected and needing hospitalization after getting two shots, and hundreds of them (9%) have died… (CNN)
The report proves that the vaccines, though frequently touted by the USA government and the mass media, are not guaranteed to prevent everyone from contracting the virus.
That wasn’t supposed to happen. But it is happening.
Meanwhile, there is a lot of uncertainty about how the current vaccines will fare against variants that have already developed and variants that will develop in the future.
At this point, we just don’t know how effective the vaccines will be, but the New York Times is assuring us that we don’t have anything to be concerned about…
“I use the term ‘variants,’” said Dr. Eric Topol, professor of molecular medicine at Scripps Research in La Jolla, Calif., referring to much of the media coverage of the variants.
People are made scared unnecessarily to accept more vaccinations and restrictive measures. If you are fully vaccinated, two weeks post-dose you shouldn’t have to worry about variants at all.” That was the initial mantra…
The reason why a new flu vaccine comes out every year is that the flu is constantly changing and mutating. And the regular yearly flu epidemics are caused by Influenza A and B and the family of the Coronaviruses.
The same thing is happening to COVID, and there are already dozens of mutant variations spreading around the globe.
Two doses of the AstraZeneca Covid-19 vaccine were found to have only a 10.4% efficacy against mild-to-moderate infections caused by the B.1.351 South Africa variant, according to a phase 1b-2 clinical trial published on Tuesday in the New England Journal of Medicine. This study was completely funded by the Bill and Melinda Gates Foundation and other **foundations which are linked to the Bill and Melinda Foundation. The conclusion of the study was the current mRNA vaccines do not give protection to many mutants. (Reference: March 16, 2021 / DOI: 10.1056/NEJMoa2102214 and funded by the Bill and Melinda Gates Foundation and others; ClinicalTrials.gov number, NCT04444674. opens in a new tab; Pan African Clinical Trials Registry number, PACTR202006922165132)
We also have not even discussed all of the side effects that we have been witnessing. A few days ago, the FDA issued an unprecedented halt order regarding the Johnson and Johnson vaccine because it was causing multiple rare brain blood clots in an increasing number of cases.
When the news broke about the pause of the Johnson & Johnson vaccine Tuesday, one Coast family was already living with a tragedy they believe was caused by the vaccine.
It should not be controversial to say that rushing experimental vaccines through the testing process was a really bad idea.
We should be putting the safety of the people first, and nobody knows for sure what the long-term effects of these experimental treatments will be. Of great concern are the likely autoimmune diseases that will occur one to two years after inoculation.
In this day and age, we all need to do our own research and we all need to think for ourselves because the big pharmaceutical companies are more concerned with profits than anything else.
If you are harmed by their experimental therapies, the big pharmaceutical companies won’t be there to pick up the pieces for you if something goes horribly wrong. The taxpayer will do…..
**Supported by the Bill and Melinda Gates Foundation (INV-017710), and through them, the South African Medical Research Council (96167), U.K. Research and Innovation (MC_PC_19055), and the U.K. National Institute for Health Research. Vaccine production was funded by AstraZeneca. The University of Oxford has legal responsibility as sponsor of the trial. Personnel from the Keertan Dheda laboratory were supported by the South African Medical Research Council–University of Cape Town Centre for the Study of Antimicrobial Resistance (RFA-EMU-02-2017) and the European and Developing Countries Clinical Trials Partnership (EDCTP) (TMA-2015SF-1043 and TMA-1051-TESAII). Dr. Esmail is supported by the EDCTP (TMA-2015CDF-1052). Additional funding was received from the South African Medical Research Council Strategic Health Innovation Partnerships (SHIP) program. Dr. Moore is supported by a grant (98341) from the South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation. Dr. Wibmer is supported by the Fogarty International Center, National Institutes of Health (R21TW011454), and by the FLAIR fellowship program (FLR\R1\201782).